The Department of Industry, Innovation and Science, under the Australia-India Strategic Research Fund, invites applications for its COVID-19 collaborative research project grants. These support collaborative science, technology and biotechnology research projects with Indian counterparts that are of mutual benefit to Australia and India, this round focusing on contributing to the global response to the COVID-19 pandemic. The priority areas for round 13 – COVID 19 collaborative research projects are:
- Antiviral coatings, other preventive technologies
- Data analytics, modelling, Artificial Intelligence applications
- Screening and diagnostic testing
- Development of immunotherapeutics
- Development of animal model/ in vitro model for vaccine development
- Assay development and validation for testing of vaccines and therapeutics
- Viral genomics and bioinformatics
Funding
Grants are worth between $300,000 and $600,000.
Eligibility
To be eligible you must:
- have an Australian Business Number (ABN), and
- be one of the following entities:
- a company, incorporated in Australia
- an incorporated not for profit organisation
- a publicly funded research organisation (PFRO)
- a Cooperative Research Centre
- another Australian incorporated entity.
Submission Requirements & Due Date
The University can only submit a maximum of two applications:
- one with a corresponding application submitted under the Science and Technology Fund with India’s Department of Science and Technology
- one corresponding application submitted under the Biotechnology Fund with India’s Department of Biotechnology
Therefore an internal selection process will be conducted if there is more than one application under each stream. Interested candidates must notify rbinternational@adelaide.edu.au by 19 June 2020 with a short summary (maximum 2 pages) of:
- How your project will advance research in priority areas to deliver tangible outcomes and benefits for both Australia and India:
- the specific problem or issue your project will address, why it needs to be addressed, how your project will address it, including the rationale for your approach and any existing research you will build on;
- the expected outcomes and benefits of your research and how they would contribute to the global response to the COVID-19 pandemic, including demonstrating a clear path to end use such as application of outcomes for the public good and/or commercialisation.
- Your capacity, capability and resources to deliver the project:
- your access to personnel with the right skills and experience, including management and technical staff, and to any infrastructure, capital equipment, technology and intellectual property required for the project;
- a sound project plan to manage and monitor the project, including arrangements for governance and intellectual property rights and the identification of risks and mitigation strategies.